This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

JANA Partners Responds To Agrium's Proxy Circular And Defense Of The Status Quo

NEW YORK, March 4, 2013 /PRNewswire/ -- JANA Partners today responded to the release of proxy materials from Agrium Inc. ("Agrium") (TSX / NYSE: AGU).

"Agrium is proudly defiant in its continued refusal to consider any new means to reverse its historical underperformance compared to its true potential.  However, nothing in Agrium's new appeal to shareholders addresses the board's total failure to unlock Agrium's true value potential and its entrenched defense of the status quo at any cost.  After you wash away the diversions and distortions, the truth remains that Agrium has significantly underperformed its peer weighted average, has destroyed value through its failed strategy and lack of proper board oversight, and would benefit greatly from the experience, independence and shareholder mindset that our nominees will bring to Agrium's board.

Agrium continues to focus only on our comments about its conglomerate structure because they have no compelling response on the issues we have raised with respect to costs, controls, capital allocation and corporate governance.  As for the issue of structure, Agrium pounds its chest but the fact is that the board has refused to conduct anything other than a rigged review of Agrium's persistent undervaluation based on distorted analysis.  A board in search of all means to deliver value for shareholders would conduct a searching review of the issue and accept whatever the results are, as our independent nominees would do.

With respect to Agrium's attacks on our directors, this is another diversionary tactic from a board that knows it is losing shareholders because of its inability to unlock Agrium's true value potential. The truth is that our nominees only stand to gain to the extent that all shareholders gain and each meets the independence requirements of the CBCA, the NYSE and Agrium's own governance guidelines.  Agrium has known this since we first disclosed our director nominees four months ago but is raising it now out of desperation.  It is also preposterous that a board chairman that has purchased literally zero shares personally in almost seven years and a board that overall has invested so little personally in their own stock, and has acted accordingly, would seek to make an issue out of director alignment with shareholders.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs